CWM
BMY icon

Concentric Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Concentric Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.83M Buy
54,695
+3,605
+7% +$169K 0.69% 56
2024
Q2 		$2.12M Buy
51,090
+3,133
+7% +$140K 0.55% 60
2024
Q1 		$2.6M Buy
47,957
+4,245
+10% +$216K 0.69% 57
2023
Q4 		$2.24M Buy
43,712
+7,119
+19% +$374K 0.65% 58
2023
Q3 		$2.12M Buy
36,593
+770
+2% +$47.2K 0.7% 56
2023
Q2 		$2.29M Buy
35,823
+1,237
+4% +$82.9K 0.73% 57
2023
Q1 		$2.4M Buy
34,586
+179
+0.5% +$12.6K 0.79% 53
2022
Q4 		$2.48M Sell
34,407
-252
-0.7% -$19K 0.85% 49
2022
Q3 		$2.46M Buy
34,659
+85
+0.2% +$6.17K 0.91% 45
2022
Q2 		$2.66M Buy
34,574
+325
+0.9% +$24.8K 0.9% 46
2022
Q1 		$2.5M Buy
34,249
+680
+2% +$45.7K 0.72% 55
2021
Q4 		$2.09M Buy
33,569
+3,190
+11% +$187K 0.59% 63
2021
Q3 		$1.8M Buy
30,379
+2,258
+8% +$149K 0.55% 64
2021
Q2 		$1.88M Buy
28,121
+924
+3% +$60.3K 0.58% 64
2021
Q1 		$1.72M Buy
27,197
+4,410
+19% +$274K 0.57% 63
2020
Q4 		$1.41M Buy
22,787
+2,690
+13% +$165K 0.52% 68
2020
Q3 		$1.21M Buy
20,097
+25
+0.1% +$1.5K 0.52% 66
2020
Q2 		$1.18M Sell
20,072
-415
-2% -$24.8K 0.55% 62
2020
Q1 		$1.14M Buy
20,487
+1,955
+11% +$119K 0.63% 59
2019
Q4 		$1.19M Buy
18,532
+11,792
+175% +$675K 0.51% 64
2019
Q3 		$342K Buy
6,740
+140
+2% +$6.58K 0.22% 75
2019
Q2 		$299K Buy
6,600
+2,105
+47% +$98K 0.19% 78
2019
Q1 		$214K Buy
+4,495
New +$224K 0.14% 85

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Concentric Wealth Management's BMY Position: Q3 2024 in Review

Concentric Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 7.1% in Q3 2024, buying an estimated $169K and bringing the position to 54,695 shares worth $2.83M. The position accounts for 0.69% of the portfolio, ranked #56.

Concentric Wealth Management first reported a position in BMY in Q1 2019 and has held it in 23 quarters since. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Concentric Wealth Management held 54,695 shares of Bristol-Myers Squibb worth $2.83M as of Q3 2024.
  • Concentric Wealth Management bought 3,605 Bristol-Myers Squibb shares in Q3 2024, an estimated $169K.
  • Bristol-Myers Squibb made up 0.69% of Concentric Wealth Management's portfolio in Q3 2024, its #56 holding.
  • Concentric Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 23 quarters since.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Concentric Wealth Management's 13F filing for Q3 2024, filed 13 Nov 2024.